FDA Adverse Event
Injury
Summary report: N
0.8% RESOLVE PANEL A
MDR report key: 1834065
·
Received September 14, 2010
Report
- Report Number
- 2250051-2010-00210
- Event Type
- Injury
- Date Received
- September 14, 2010
- Date of Event
- August 29, 2010
- Report Date
- September 14, 2010
- Manufacturer
- ORTHO CLINICAL DIAGNOSTICS
- Product Code
- KSZ
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
RETAINED TESTING AND BATCH RECORD REVIEW WERE PERFORMED. SATISFACTORY RESULTS WERE OBSERVED.(B)(4)
Description of Event or Problem · 1
PATIENT WITH NO PREVIOUS ANTIBODY HISTORY AND A POSITIVE ANTIBODY SCREEN DID NOT REACT WITH VRA146. COMPATIBILITY TESTING WAS PERFORMED AND 3 UNITS OF COMPATIBLE BLOOD WERE TRANSFUSED. PATIENT SHOWED NO SIGNS/SYMPTOMS OF A TRANSFUSION REACTION DURING THE TRANSFUSION. PATIENT WAS LATER IDENTIFIED AS HAVING AN ANTI-E WHEN TESTING WAS PERFORMED WITH FICIN TREATED CELLS. TWO OF THE UNITS OF PACKED CELLS THAT HAD BEEN TRANSFUSED WERE E+. THE FOLLOWING DAY THE PATIENT HAD A POSITIVE DAT AND ANTI-E WAS IDENTIFIED IN THE ELUATE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | 0.8% RESOLVE PANEL A | REAGENT RED BLOOD CELLS | KSZ | ORTHO CLINICAL DIAGNOSTICS | VRA146 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |